PRF1 and neoplasm: Previous studies have shown that TILs can exert both tumor suppressive and tumor-promoting effects; for instance, activated cytotoxic T lymphocytes (CTLs) kill tumor cells by releasing perforin and granzymes [6], and Tregs promote tumor immune escape through the suppression of antitumor immune responses [7].